The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
Quiz|Articles|September 18, 2025
The Compliance Crisis Quiz: How Well Do You Know Cannabis Regulations?
Author(s)Madeline Colli
Listen
0:00 / 0:00
Key Takeaways
- The cannabis industry must navigate evolving regulations and inconsistent lab testing to maintain compliance in 2025.
- Weak recordkeeping practices complicate compliance efforts, necessitating improvements for effective regulatory adherence.
Test your knowledge of cannabis compliance in 2025. This quiz covers key issues like cross-state expansion and FDA oversight.
Advertisement
The blog "The Compliance Crisis: 10 Emerging Cannabis Compliance Issues in 2025" discusses various challenges facing the cannabis industry. Key issues include navigating constantly changing regulations, inconsistent lab testing, weak recordkeeping, and adapting to potential federal oversight from the FDA.
Read more about Stuck on Compliance's blog post
According to the article, what is a primary cause of 'regulatory fatigue' in the cannabis industry?
Advertisement
Related to this article
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
High Tide expressed their support for the recent executive order instructing federal agencies to reschedule cannabis.
President Trump signed an executive order directing federal agencies to reclassify cannabis from Schedule I to Schedule III controlled substances.
A recent study found that medical cannabis may play a role in decreasing opioid use.
The new dispensary will operate under the Trulieve brand by Harvest Grows LLC, amid new legislation changes in the state.
Advertisement
Advertisement